Transarterial chemoembolization (TACE) in patients with unresectable diffuse vs. focal hepatocellular carcinoma (HCC).

被引：1
|
作者：
Pan, SH [1 ]
Ramirez, C [1 ]
Hoffman, A [1 ]
Sher, L [1 ]
Rojter, S [1 ]
Lopez, RR [1 ]
机构：
[1] St Vincents Med Ctr, Los Angeles, CA USA
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)86110-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1136
引用
收藏
页码：A991 / A991
页数：1
相关论文
共 50 条
  • [21] Transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma - a useful tool ?
    Meister, Tobias
    Heinzow, Hauke
    Lenz, Philipp
    Ullerich, Hansjoerg
    Domschke, Wolfram
    Domagk, Dirk
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S129 - S130
  • [22] Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial
    Ikeda, Masafumi
    Kudo, Masatoshi
    Aikata, Hiroshi
    Nagamatsu, Hiroaki
    Ishii, Hiroshi
    Yokosuka, Osamu
    Torimura, Takuji
    Morimoto, Manabu
    Ikeda, Kenji
    Kumada, Hiromitsu
    Sato, Tosiya
    Kawai, Ikuko
    Yamashita, Toru
    Horio, Hiroshi
    Okusaka, Takuji
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (02) : 281 - 290
  • [23] Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial
    Masafumi Ikeda
    Masatoshi Kudo
    Hiroshi Aikata
    Hiroaki Nagamatsu
    Hiroshi Ishii
    Osamu Yokosuka
    Takuji Torimura
    Manabu Morimoto
    Kenji Ikeda
    Hiromitsu Kumada
    Tosiya Sato
    Ikuko Kawai
    Toru Yamashita
    Hiroshi Horio
    Takuji Okusaka
    Journal of Gastroenterology, 2018, 53 : 281 - 290
  • [24] Transarterial chemoembolization vs. conservative treatment for unresectable infiltrating hepatocellular carcinoma: A retrospective comparative study
    Dai, Qiang-Sheng
    Gu, Hong-Lin
    Ye, Sheng
    Zhang, Yao-Jun
    Lin, Xiao-Jun
    Lau, Wan Yee
    Peng, Zhen-Wei
    Chen, Min-Shan
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (06) : 1047 - 1054
  • [25] Stereotactic body radiotherapy (SBRT) as an alternative to transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC)
    Sapir, Eli
    Tao, Yebin
    Parikh, Neehar D.
    Bazzi, Latifa
    Devlin, Pauline
    Novelli, Paula M.
    Cuneo, Kyle Clifford
    Lawrence, Theodore Steven
    Schipper, Matthew J.
    Feng, Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Transarterial chemoembolization (TACE) with doxorubicin eluting beads (DEB) for the treatment of hepatocellular carcinoma (HCC)
    Vit, A.
    De Pauli, F.
    Sponza, M.
    Mazzer, M.
    Foltran, L.
    Montanari, M.
    Piccoli, G.
    Fasola, G.
    Gasparini, D.
    Aprile, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] Doxorubicin eluting bead (DEB) transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma (HCC)
    De Pauli, Federica
    Vit, Alessandro
    Aprile, Giuseppe
    Sponza, Massimo
    Iaiza, Emiliana
    Zanon, Elisa
    Piccoli, Gianluca
    Marzio, Andrea
    Giovannoni, Mariella
    Fasola, Gianpiero
    Gasparini, Daniele
    ANNALS OF ONCOLOGY, 2007, 18 : 9 - 9
  • [28] Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: Functional hepatic reserve and survival
    Grieco, A
    Marcoccia, S
    Miele, L
    Marmiroli, L
    Caminiti, G
    Ragazzoni, E
    Cotroneo, AR
    Cefaro, GA
    Rapaccini, GL
    Gasbarrini, G
    HEPATO-GASTROENTEROLOGY, 2003, 50 (49) : 207 - 212
  • [29] Regorafenib combined with transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (HCC) with previous systematic treatment: A preliminary investigation of safety and efficacy
    Han, Y.
    Cao, G.
    Sun, B.
    Wang, J.
    Yan, D.
    Xu, H.
    Shi, Q.
    Liu, Z.
    Xu, L.
    Liu, B.
    Zou, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S1309 - S1309
  • [30] Is transarterial chemoembolization an option for all patients with unresectable hepatocellular carcinoma?
    Burroughs, Andrew
    Samonakis, Dirnitrios
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (02): : 78 - 79
12345